This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Food Allergy
  • /
  • Diagnostic Accuracy and Safety of DBV1605 for the ...
Clinical trial

Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children (APTITUDE)

Read time: 1 mins
Last updated:11th Apr 2021
Status: Recruiting
Identifier: NCT04492683
Diagnostic Accuracy and Safety of DBV1605 for the Diagnosis of Non-IgE Mediated Cow's Milk Allergy in Children (APTITUDE)


Study to assess the diagnostic accuracy (sensitivity, specificity, positive and negative predictive value) of DBV1605 for the diagnosis of non-Immunoglobulin E (IgE) mediated cow's milk allergy (CMA) in children with symptoms suggestive of non-IgE mediated CMA.


Study Type: Interventional (Clinical Trial)
Estimated Enrollment: 230 participants
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: A Phase 2 Study to Evaluate the Sensitivity, Specificity and Safety of DBV1605, a Ready-to-Use Atopy Patch Test for the Diagnosis of Non-Immunoglobulin E Mediated Cow's Milk Allergy in Children
Actual Study Start Date: August 28, 2020
Estimated Primary Completion Date: June 2021
Estimated Study Completion Date: June 2021

Arm:
- Experimental: Disease group
- Experimental: Control group

Category Value
Study type(s) Interventional
Estimated enrolment 230
Actual Study start date 28 August 2020
Estimated Study Completion Date 01 June 2021

View full details